News tagged with neuropsychopharmacology
Neuropsychopharmacology
Neuropsychopharmacology (from Greek νεῦρον, neuron, "nerve"; ψυχή, psyche, "mind", "soul"; φάρμακον, pharmakon, "poison in classic Greek; drug in modern Greek" and the suffix -λογία, -logia, "study of") is an interdisciplinary science related to psychopharmacology (how drugs affect the mind) and fundamental neuroscience. It entails research of mechanisms of neuropathology, pharmacodynamics (drug action), psychiatric illness, and states of consciousness. These studies are instigated at the detailed level involving neurotransmission/receptor activity, bio-chemical processes, and neural circuitry. Neuropsychopharmacology supersedes psychopharmacology in the areas of "how" and "why", and additionally addresses other issues of brain function. Accordingly, the clinical aspect of the field includes psychiatric (psychoactive) as well as neurologic (non-psychoactive) pharmacology-based treatments.
Developments in neuropsychopharmacology may directly impact the studies of anxiety disorders, affective disorders, psychotic disorders, degenerative disorders, eating behavior, and sleep behavior.
The rigorous way fundamental processes of the brain are being discovered is creating a field on par with other “hard sciences” such as chemistry, biology, and physics, so that eventually it may be possible to repair mental illness with ultimate precision. An analogy can be drawn between the brain and an electronic device: neuropsychopharmacology is tantamount to revealing not only the schematic diagram, but the individual components, and every principle of their operation. The bank of amassed detail and complexity involved is huge; mere samples of some of the details are given in this article.
This account hangs on the assumption that materialism, the view that all mental states are reducible to brain states, is true.
For more information about Neuropsychopharmacology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Experimental treatments for cocaine addiction may prevent relapse
Doctors have used the drug disulfiram to help patients stay sober for several decades. It interferes with the body's ability to metabolize alcohol, giving a fierce hangover to someone who consumes even a small amount of alcohol.
Medicine & Health / Medical research
Aug 26, 2010 |
5 / 5 (1) |
0
Parkinson's patients' 'risky behavior' explained
Scientists at UCL (University College London) have explained Parkinson's patients' risky behaviour, a rare side effect of standard treatments for the disease. The finding has implications for future medication of patients.
Medicine & Health / Psychology & Psychiatry
Jun 23, 2010 |
5 / 5 (1) |
0
Sleep patterns in children and teenagers could indicate risk for depression
Sleep patterns can help predict which adolescents might be at greatest risk for developing depression, a researcher at UT Southwestern Medical Center has found in a five-year study.
Medicine & Health / Psychology & Psychiatry
Aug 13, 2009 |
3.3 / 5 (3) |
0